NTRA
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- Natera and TransCode Therapeutics announce a collaboration on a Phase 2a trial of TTX-MC138 in colorectal cancerOct 13, 2026
- Signatera receives regulatory approval in Japan as a companion diagnostic for muscle-invasive bladder cancerSep 22, 2026
- A large MRD study in lung cancer demonstrated strong prognostic value for SignateraSep 18, 2026
- Natera and Angiex partnered to assess response to an investigational nuclear-delivered antibody-drug conjugate using SignateraAug 27, 2026
- Natera submitted Signatera to Japan's PMDA for approval as a companion diagnostic in muscle-invasive bladder cancerAug 6, 2026